Sound Capital Solutions’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Sound Capital Solutions's AMLX Position: Q3 2026 in Review
Sound Capital Solutions sold out of Amylyx Pharmaceuticals (AMLX) in Q3 2026, closing a stake of 31,890 shares — an estimated $573K sold.
Sound Capital Solutions first reported a position in AMLX in Q2 2026 and held it in 1 quarter. The position peaked at $573K in Q2 2026. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Sound Capital Solutions reported no remaining Amylyx Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Sound Capital Solutions sold 31,890 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $573K.
- Sound Capital Solutions first reported a position in Amylyx Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Sound Capital Solutions's Amylyx Pharmaceuticals position peaked at $573K in Q2 2026.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Sound Capital Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.